产品详细信息
- 我们的分析型开发及质量控制能力包括：
- HPLC 色谱技术
- 标准 HPLC 检测性能
- HPLC-质谱
- 气相色谱 (GC)
- 相变熔解分析 (TM)
- 卡氏容量法水分测定
- 库伦滴定水分测定
- 渗透压
- 内毒素分析
- 总有机碳分析 (TOC)
- 傅里叶变换红外光谱 (FTIR)
- 核磁共振 (NMR)
- 紫外光谱 (UV)
- 金属分析
- 粘度测定
- 自动滴定
- 我们的设施和设备经验证符合 Q7 人用药品注册技术要求国际协调会 (ICH) 确认指南中现行药品生产质量管理规范 (GMP) 的规定。
- 产品样本
-
Brochure - NASD - Delivering Solutions for Nucleic Acid Therapeutics
Nucleic Acid Solutions Division Overview Brochure.
- 产品样本
- English
- 2020 年 6 月 15 日
- 3.37 MB
- 宣传单页
Senior Director
Process chemistry
We like the collaborative nature of our partnership. Agilent works with us to truly understand our needs and how to best meet them, even when they change overtime.
查看更多Scientific Director
Analytical Development
Agilent provides program guidance and suggestions based on their extensive internal expertise, which helps avoid “re-inventing the wheel”.
查看更多视频
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
Investment will double capacity to produce active pharmaceutical ingredients used in therapeutics for a broad range of diseases. The addition of two new manufacturing lines (known as Trains C and D) will enable Agilent to meet growing demand for siRNA, antisense and CRISPR guide RNA molecules. Agilent expects customer shipments from the expansion to begin in 2026.
- 2022 年 12 月 5 日